… are freqcuently found in breast cancers and associated with cellular transformation,
tumorigenesis, cancer progression, and drug resistance. Several drugs targeting PI3K/ATK/mTOR …

… Clinical trials targeting PI3K have also attracted increasing attention. Emerging … with the
PI3K/AKT pathway to regulate cancer progression. Importantly, circRNAs related to the PI3K/AKT …

… Several studies using GEMs subsequently showed that tissue-specific expression of mutant
PIK3CA can induce tumor formation and accelerate cancer progression (13–15). PIK3CD …

… of cell survival, cell cycle progression and cellular growth. In recent years, it has been
shown that PI3K/Akt signalling pathway components are frequently altered in human cancers. …

… direct connection between the PI3K-AKT-mTOR and androgen … number of novel inhibitors
of the PI3K pathway, which offer the … of the PI3K-AKT-mTOR pathway in PCa progression and …

… a challenge for cancer therapy. The high recurrence of phosphoinositide 3-kinase (PI3K)
pathway adjustments in cancer has led to a surge in the progression of PI3K inhibitors. Recent …

… The PI3K/AKT signalling pathway has … of PI3K/AKT signalling in gastric cancer progression
is well established, little is known about the role of SLC1A3 in the regulation of the PI3K/AKT …

… One such pathway is the PI3K/AKT/… PI3K/AKT/mTOR pathway. In this review, the focus will
be on recent research implicating the PI3K/AKT/mTOR pathway in ovarian cancer progression …

… between cytoskeletal proteins and the PI3K/AKT signaling pathway, and how … aids cancer
progression. Our review also summarizes recent advances in the clinical development of PI3K …

… that the PI3K/Akt pathway is a viable target for novel antineoplastic drugs. This review will
describe PI3K/Akt pathway signaling and its effects on cell cycle progression, prevention of …